NCT02109770View on ClinicalTrials.gov

Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA

CompletedOBSERVATIONAL
Enrollment

216

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2019

Study Completion Date

August 31, 2019

Conditions
Microdeletion SyndromesTrisomy 21Trisomy 18Trisomy 13Sex Chromosome Abnormalities
Trial Locations (2)

19104

Children's Hospital Of Philadelphia, Philadelphia

94070

Natera, San Carlos

Sponsors

Lead Sponsor

Natera, Inc.
All Listed Sponsors
lead

Natera, Inc.

INDUSTRY

NCT02109770 - Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA | Biotech Hunter | Biotech Hunter